Amivantamab is effective in NSCLC harbouring EGFR exon 20 insertions
Crossref DOI link: https://doi.org/10.1038/s41571-021-00551-8
Published Online: 2021-08-11
Published Print: 2021-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2021-08-11
Version of Record valid from 2021-08-11
Article History
First Online: 11 August 2021